DMIIU
DMIIU
Drugs Made In America Acquisition II Corp. Unit • NASDAQ
$10.02 ▼ -0.20% (-0.02)
Market Cap $638.59 M
52w High $10.06
52w Low $9.94
Dividend Yield 0%
P/E 0
Volume 15.04K
Outstanding Shares 63.70M
Market Cap $638.59 M
52w High $10.06
52w Low $9.94
Dividend Yield 0%
P/E 0
Volume 15.04K
Outstanding Shares 63.70M
About Drugs Made In America Acquisition II Corp. Unit
A SPAC (blank check company) incorporated in the Cayman Islands to pursue a business combination. The company aims to focus on pharmaceutical / drug sector targets to reduce U.S. reliance on global drug manufacturing. Each unit consists of one ordinary share and one right to receive one-tenth of a share upon completion of a qualifying business combination.
CEO
Lynn Stockwell
Compensation Summary
(Year 2024)
Salary $0
Bonus $0
Stock Awards $0
Option Awards $0
Incentive Plan Pay $0
All Other Compensation $0
Outstanding Value $0
Total Compensation (Unknown At The Moment)
CEO
Lynn Stockwell
Compensation Summary
(Year 2024)
Salary $0
Bonus $0
Stock Awards $0
Option Awards $0
Incentive Plan Pay $0
All Other Compensation $0
Outstanding Value $0
Total Compensation (Unknown At The Moment)
Industry Asset Management
Sector Financial Services
Went public September 25, 2025
Method of going public SPAC
Full time employees 2